Research / CRNC / Fundamental state Inspectable configuration
State dimensions Filing 0000950170-25-015440 General Corporate
Debt relative to revenue 100th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
503.30% · OPTIONAL · VALID
Capex intensity 40th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
2.67% · OPTIONAL · VALID
Operating cash generation 80th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
18.18% · OPTIONAL · VALID
Revenue growth 0th Own-history percentile · N=16
Evidence method Yoy · gp.fundamentals.revenue
-63.21% · CORE · VALID
Inventory pressure RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
3.54% · OPTIONAL · NOT_ENOUGH_HISTORY
Gross margin 10th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
64.98% · CORE · VALID
Operating margin 20th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
-33.27% · CORE · VALID
R&D intensity 75th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
41.00% · OPTIONAL · VALID
SBC intensity 85th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
15.27% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 27 states Self-history eligible
Sep 30, 2021 0/8 normalized Level 3 Dec 31, 2021 7/8 normalized Level 3 Mar 31, 2022 7/8 normalized Level 3 Jun 30, 2022 7/8 normalized Level 3 Sep 30, 2022 7/8 normalized Level 3 Dec 31, 2022 8/8 normalized Level 3 Mar 31, 2023 8/8 normalized Level 3 Jun 30, 2023 8/8 normalized Level 3 Sep 30, 2023 8/8 normalized Level 3 Dec 31, 2023 8/9 normalized Level 3 Mar 31, 2024 8/9 normalized Level 3 Jun 30, 2024 8/9 normalized Level 3 Sep 30, 2024 8/9 normalized Level 3 Dec 31, 2024 8/9 normalized Level 3 Mar 31, 2025 8/9 normalized Level 3 Jun 30, 2025 8/9 normalized Level 3 Sep 30, 2025 8/9 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 9/9 normalized Level 3 Jun 30, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 85.04%
Current 503.30%
Delta 418.27% Capex Intensity Increased
Previous 1.51%
Current 2.67%
Delta 1.17% Cash Generation Increased
Previous 5.19%
Current 18.18%
Delta 12.99% Growth Decreased
Previous 12.57%
Current -63.21%
Delta -75.78% Inventory Pressure Increased
Previous 0.30%
Current 3.54%
Delta 3.23% Margin Decreased
Previous 73.69%
Current 64.98%
Delta -8.71% Profitability Increased
Previous -174.94%
Current -33.27%
Delta 141.67% R And D Intensity Increased
Previous 36.67%
Current 41.00%
Delta 4.33% Sbc Intensity Increased
Previous 7.14%
Current 15.27%
Delta 8.13% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.